Charles River Labs Intl sell Citigroup Inc.
Start price
01.10.24
/
50%
€175.45
Target price
01.10.25
€158.03
Performance (%)
-17.50%
End price
02.10.25
€144.75
Summary
This prediction ended on 02.10.25 with a price of €144.75. The price of Charles River Labs Intl decreased from the start of the prediction. Compared to the start price this resulted in a performance of -17.50%. Citigroup_Inc_ has a follow-up prediction for Charles River Labs Intl, but this time predicts that Charles River Labs Intl is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | 0.949% | 0.949% | -6.080% |
| iShares Core DAX® | -0.479% | -12.062% | -2.949% |
| iShares Nasdaq 100 | -3.377% | -5.130% | 9.585% |
| iShares Nikkei 225® | -0.143% | -12.633% | 20.316% |
| iShares S&P 500 | -2.266% | -5.049% | 5.803% |
Comments by Citigroup_Inc_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $175.00 price target on the stock, down previously from $215.00.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€135.75
09.07.25
09.07.25
€170.62
09.07.26
09.07.26
1.84%
27.03.26
27.03.26
